Development and validation of three colorimetric charge transfer complexes for estimation of fingolimod as an antineoplastic drug in pharmaceutical and biological samples

Basavaiah K, Zenita O (2011) Spectrophotometric determination of famotidine using sulphonphthalein dyes. Quim Nova 34:735–742 Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Burns C, Prieschl E, Baumruker T, Hiestand P, Foster CA, Zollinger M, Lynch KR (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277:21453–21457. https://doi.org/10.1074/jbc.C200176200 Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, Aradhye S, Burtin P (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 9:883–897 Chhabda PJ, Balaji M, Srinivasarao V (2013) Development and validation of a stability indicating RP-HPLC method for quantification of fingolimod in bulk and pharmaceutical dosage form. Pharmanest 4:1206–1218 Chiba K (2005) FTY720, a new class of immonomodulator, inhibits lymphocyte egres from secondry lymphoid issues and thymus by agonistic activity at sphingosine 1- phosphate receptors. Pharm Ther 108:308–319 Effat S, Mohammad Z, Siavash M, Reza A, Abbas K (2015) A stability-indicating HPLC method for the determination of fingolimod in pharmaceutical dosage forms. Sci Pharm 83:85–93 El-Adl SM, El-sadek ME, Hassan MH (2019) spectrophotometric analysis of azithromycin and clarithromycin in tablets and human plasma using p-chloranilic acid. Anal Chem Lett 9(3):362–372 Emotte C, Deglave F, Heudi O, Picard F, Kretz O (2012) Fast simultaneous quantitative analysis of FTY720 and its metabolite FTY720-P in human blood by on-line solid phase extraction coupled with liquid chromatography-tandemmass spectromertry. J Pharm Biomed Anal 58:102–112. https://doi.org/10.1016/j.jpba.2011.09.021 Fernandes GM et al (2020) Novel approaches for colorimetric measurements in analytical chemistry–a review. Anal Chim Acta 1135:187–203 Ferreiros N, Labocha S, Schroder M, Radeke HH, Geisslinger G (2012) LC-MS/MS determination of FTY720 and FTY 720- phosphate in murine intracellular ompartments and human plasma. J Chromatoogr B 887–888:122–127. https://doi.org/10.1016/j.jchromb.2012.01.023 Islam A, Emad B (2016) Method development and validation for fingolimod by HPLC/UV in immediate-release oral capsule and study the effect of excipients on solubility and dissolution behavior. J Anal Pharm Res 2(1):00008 Jian-Rong W, Sha L, Bingqing Z, Xuefeng M (2015) Insight into the conformational polymorph transformation of ablock-buster multiple sclerosis drug fingolimod hydrochloride(FTY 720). J Pharm Biomed Anal 109:45–51 Kailasa SK, Park T-J, Koduru JR (2019) Metal nanoparticles-based colorimetric methods for drug analyses. Nanoarchitectonics in Biomedicine. Elsevier, New York, pp 619–641 Lantam A et al (2020) A portable optical colorimetric sensor for the determination of promethazine in lean cocktail and pharmaceutical doses. Microchem J 159:105519 Moffat AC et al (2000) Meeting the International Conference on Harmonisation’s Guidelines on Validation of Analytical Procedures: Quantification as exemplified by a near-infrared reflectance assay of paracetamol in intact tabletsThe opinions expressed in the following article are entirely those of the authors and do not necessarily represent the views of either The Royal Society of Chemistry or the Editor of The Analyst. Analyst 125(7):1341–1351 Narasimha RK, ChVS N, Rajan ST, Eshwaraiah S, Sampath Kumar RG, Rakesh M, Seetha Rama SP, Kishore M, Chakavarthy IE (2014) Stability indicating HPLC method for the quantification of fingolimod hydrochloride and its related substances. Der Pharma Chem 6:335–342 Ravi V, Madhavi P, Darshana P, Anamik K, Ranjan C (2016) Development and validation of immunomodulating drug fingolimod by RPHPLC method with detailed force degradation study. Chem Biol Interface 6(4):210–223 Salem H, Elsoud FAA, Heshmat D (2021) Spectrofluorimetric analysis of fingolimod via complex formation with eosin Y in its pure form, pharmaceutical preparation and biological samples. Spectrochim Acta Part A Mol Biomol Spectrosc 250:119331 Salm P, Warnholtz CR, Lynch SV, Taylor PJ (2006) Measurement and stability of FTY720 in human whole blood by high-performance-atmospheric pressure chemical ionization-tandem mass spectrometry. J Chromatogr B 843:157–163. https://doi.org/10.1016/j.jchromb.2006.05.026 Shrivas K et al (2017) Label-free selective detection of ampicillin drug in human urine samples using silver nanoparticles as a colorimetric sensing probe. New J Chem 41(14):6685–6692 Somsubhra G, Ravikumar B (2015) Development of stability indicating RP-HPLC method for the estimation of Fingolimod in its bulk dosages form as per ICH guideline. J Chem Pharm Res 7(2):23–29 Somsubhra G, Laxmi P, Sowjanya B, David B (2014) Analytical method development and validation of fingolimod in bulk drug by spectrophotometric method as per ICH guidelines. Asian J Res Chem 7(1):55–57 Son SU et al (2021) Colorimetric paper sensor for visual detection of date-rape drug c-hydroxybutyric acid (GHB). Sens Actuat B 347:130598 Suneethaa S, Rajeswari K (2016) A high throughput flow gradient LC–MS/MS method for simultaneous determination of fingolimod, fampridine and prednisone in ratplasma, application to in vivo perfusion study. J Pharm Biomed Anal 120:10–18 Zhila A, Eslam P, Abolghasem B (2016) Mixed hemimicelles solid-phase extraction based on sodium dodecyl sulfate (SDS)-coated nano-magnets for the spectrophotometric determination of fingolomid in biological fluids. Spectrochim Acta A Mol Biomol Spectrosc 15(153):599–604. https://doi.org/10.1016/j.saa.2015.09.013 Zollinger M, Gshwind HP, Jin Y, Sayer C, Zecri F, Hartmann S (2011) Absorption and disposition of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in healthy volunteers: a case of xenobiotic biotrans formation following endogenous metabolic pathways. Drug Metab Dispos 39:199–207. https://doi.org/10.1124/dmd.110.035907